Results 241 to 250 of about 5,734,519 (291)

Analysis of nationwide adverse event reports on Isoniazid and Rifampin in tuberculosis prevention and treatment in South Korea. [PDF]

Sci Rep
Ryu J, Lee Y, Kwon JW.
europepmc   +1 more source

A post-marketing disproportionality analysis of the safety of ribociclib based on the FDA Adverse Event Reporting System. [PDF]

Ther Adv Drug Saf
Xu J, Wang R, Shen K.
europepmc   +1 more source

Drug-induced herpes zoster: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024. [PDF]

Front Pharmacol
Xia J, Zhang J, Zhu H, Ding L.
europepmc   +1 more source

Behavioral Economic Strategies Increase Adverse Event Reporting in Pediatric Anesthesia. [PDF]

Clinicoecon Outcomes Res
Guan TK, Willer BL, Stevens J, Tobias JD, Olbrecht VA.   +4 more
europepmc   +1 more source

Reply: [Post-marketing safety concerns with Lecanemab: a disproportionality analysis using the FDA adverse event reporting system]. [PDF]

Alzheimers Res Ther
Xing X, Wang K, Dong X.
europepmc   +1 more source

Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system. [PDF]

Sci Rep
Liu F, Su H, Wei W.
europepmc   +1 more source

Neurosurgical management of brain metastases in the elderly: a prospective study on adverse event prevalence and predictors. [PDF]

Neurosurg Rev
Lenga P, Scherer M, Kleineidam H, Unterberg A, Krieg SM, Dao Trong P.   +5 more
europepmc   +1 more source

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database. [PDF]

Sci Rep
Zhao S, Wang Y, Deng X, Chen X, Lu Z.
europepmc   +1 more source

Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports. [PDF]

J Int Soc Sports Nutr
Kreider RB, Gonzalez DE, Hines K, Gil A, Bonilla DA.   +4 more
europepmc   +1 more source

A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system. [PDF]

Sci Rep
He K, Zhao K, Yin T, Liu M, Liu J, Du W, Liu X, Cheng B, Zhang D, Zheng Y.   +9 more
europepmc   +1 more source